Evidence map›Paper›PMID 29213095›Full record

Trial reportScientific reports2017

Evolution of Energy Related Metabolites in Plasma from Newborns with Hypoxic-Ischemic Encephalopathy during Hypothermia Treatment.

Ángel Sánchez-Illana, Antonio Núñez-Ramiro, María Cernada, Anna Parra-Llorca, Eva Valverde, Dorotea Blanco, Maria Teresa Moral-Pumarega, Fernando Cabañas, Hector Boix, Antonio Pavon and 10 more

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Post Mortem Molecular Biomarkers of Asphyxia: A Literature Review.International journal of molecular sciences · 2024
    Review
  2. Development and validation of a multiplexed LC-MS/MS ketone body assay for clinical diagnostics.Journal of mass spectrometry and advances in the clinical lab · 2024
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Intermittent hypoxemia and oxidative stress in preterm infants.Respiratory physiology & neurobiology · 2019
    Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 14 institutions in 1 country.

Ángel Sánchez-IllanaNeonatal Research Unit, Health Research Institute La Fe, Valencia, Avda. Fernando Abril Martorell 106, 46026, Valencia, Spain.ORCID 0000-0001-7630-0614
Antonio Núñez-RamiroNeonatal Research Unit, Health Research Institute La Fe, Valencia, Avda. Fernando Abril Martorell 106, 46026, Valencia, Spain.
María CernadaNeonatal Research Unit, Health Research Institute La Fe, Valencia, Avda. Fernando Abril Martorell 106, 46026, Valencia, Spain.
Anna Parra-LlorcaNeonatal Research Unit, Health Research Institute La Fe, Valencia, Avda. Fernando Abril Martorell 106, 46026, Valencia, Spain.
Eva ValverdeHospital Universitario La Paz, Paseo de la Castellana 261, 28046, Madrid, Spain.
Dorotea BlancoHospital Universitario Gregorio Marañón, C/O'Donnell 48-50, 28009, Madrid, Spain.
Maria Teresa Moral-PumaregaHospital Universitario 12 de Octubre, Avda. de Córdoba, s/n, 28041, Madrid, Spain.
Fernando CabañasHospital Universitario Quirónsalud Madrid, Calle Diego de Velazquez s/n, 28223, Madrid, Spain.
Hector BoixHospital Universitario Vall d'Hebron, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain.ORCID 0000-0002-8613-1401
Antonio PavonHospital Universitario Virgen del Rocío, Avda. Manuel Siurot, s/n, 41013, Sevilla, Spain.
Mercedes ChaffanelHospital Materno Infantil Carlos Haya, Avda. Arroyo de los Angeles s/n, 29011, Málaga, Spain.
Isabel Benavente-FernándezHospital Universitario Puerta del Mar, Avda. Ana de Viya 21, 11009, Cádiz, Spain.
Inés TofeHospital Universitario Reina Sofía, Avda. Menendez Pidal s/n, 14004, Córdoba, Spain.
Begoña LoureiroHospital Universitario Cruces, Plaza Cruces s/n, 48903, Barakaldo, Vizcaya, Spain.
José R Fernández-LorenzoHospital Álvaro Cunqueiro, Estrada Clara Campoamor 341, 36312, Vigo, Spain.
Belén Fernández-ColomerHospital Central de Asturias, Avda. De Roma, 33011, Oviedo, Asturias, Spain.
Ana García-RoblesNeonatal Research Unit, Health Research Institute La Fe, Valencia, Avda. Fernando Abril Martorell 106, 46026, Valencia, Spain.
Julia KuligowskiNeonatal Research Unit, Health Research Institute La Fe, Valencia, Avda. Fernando Abril Martorell 106, 46026, Valencia, Spain. julia.kuligowski@uv.es.
Máximo VentoNeonatal Research Unit, Health Research Institute La Fe, Valencia, Avda. Fernando Abril Martorell 106, 46026, Valencia, Spain. maximo.vento@uv.es.ORCID 0000-0003-0061-4742
HYPOTOP Study Group
Vall d'Hebron Hospital Universitari · ESHospital de Cruces · ESHospital General Universitario Gregorio Marañón · ESHospital Universitario 12 De Octubre · ESHospital Universitario La Paz · ESHospital Universitario Puerta del Mar · ESHospital Universitario Quirónsalud Madrid · ESHospital Universitario Reina Sofía · ESHospital Universitario Virgen del Rocío · ESHospital Materno-Infantil · ESHospital Universitari i Politècnic La Fe · ESHospital Universitario Central de Asturias · ESInstituto de Investigación Sanitaria La Fe · ESUniversity Hospital Complex Of Vigo · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Therapeutic hypothermia (TH) initiated within 6 h from birth is the most effective therapeutic approach for moderate to severe hypoxic-ischemic encephalopathy (HIE). However, underlying mechanisms and effects on the human metabolism are not yet fully understood. This work aims at studying the evolution of several energy related key metabolites in newborns with HIE undergoing TH employing gas chromatography - mass spectrometry. The method was validated following stringent FDA requirements and applied to 194 samples from a subgroup of newborns with HIE (N = 61) enrolled in a multicenter clinical trial (HYPOTOP) for the determination of lactate, pyruvate, ketone bodies and several Krebs cycle metabolites at different sampling time points. The analysis of plasma samples from newborns with HIE revealed a decrease of lactate, pyruvate and β-hydroxybutyrate concentrations, whereas rising malate concentrations were observed. In healthy control newborns (N = 19) significantly lower levels of pyruvate and lactate were found in comparison to age-matched newborns with HIE undergoing TH, whereas acetoacetate and β-hydroxybutyrate levels were clearly increased. Access to a validated analytical method and a controlled cohort of newborns with HIE undergoing hypothermia treatment for the first time allowed the in-depth study of the evolution of key metabolites of metabolic junctions in this special population.

Indexed as

3-Hydroxybutyric AcidAcetoacetatesBiomarkersCase-Control StudiesFemaleGas Chromatography-Mass SpectrometryHumansHypothermia, InducedHypoxia-Ischemia, BrainInfant, NewbornKetone BodiesLactic AcidLimit of DetectionMalePyruvic Acid3-Hydroxybutyric AcidAcetoacetatesacetoacetic acidBiomarkersKetone BodiesLactic AcidPyruvic Acid

Identifiers

PMID29213095
PMCPMC5719006
OpenAlexW2771544973

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.